Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia
Status:
Completed
Trial end date:
2016-12-21
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the safety of azficel-T treatment for dysphonia
related to vocal fold function and to evaluate the efficacy of azficel-T for the treatment of
dysphonia related to vocal fold function.
Phase:
Phase 2
Details
Lead Sponsor:
Castle Creek Biosciences, LLC. Fibrocell Technologies, Inc.